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MENSTRUAL TRACKING APPLICATIONS  
 
IN WOMEN’S HEALTH STUDIES 
 
MYMY TRAN NGUYEN 
ABSTRACT 
Objective: After comparing the top 10 menstrual tracking applications, there are no 
applications that address symptoms specific to Polycystic Ovary Syndrome (PCOS). This 
thesis demonstrates the need for a comprehensive menstrual tracking application that 
caters toward all populations, including patients with PCOS.  
Methods: Mobile application usage was evaluated through data from the Ovulation and 
Menstruation (OM) Health Study to view relationships between PCOS/demographic 
groups and preference for tracking methods. The top 10 most popular mobile menstrual 
tracking applications were compiled through a search on the iOS operating system. 
Mobile menstrual tracking applications were then evaluated through an adapted 
APPLICATIONS system, which includes categories to score for PCOS-specific 
symptoms.  
Results: PCOS groups showed clear preference for tracking methods overall, and are 
more likely to view their own health as fair/poor. P values for tests between other 
demographic variables in the OM Health study were insignificant, but there are 
observable trends in education, income, and age and usage of tracking methods. 
Evaluation of the top 10 mobile menstrual applications resulted in Clue scoring the 
highest, but no applications scored a complete PCOS-specific score.  
		 vi 
Conclusions: With continual variance in menstrual cycles, there needs to be development 
of a mobile menstrual application that is effective for all populations. Mobile menstrual 
applications have proven their popularity through PCOS groups and the rising usage 
within younger age groups. However, through the adapted APPLICATIONS system, 
major features are still missing, and are necessary to cater towards unique groups such as 
people with menstrual irregularities and PCOS.  
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INTRODUCTION 
USAGE AND BENEFITS OF APPLICATIONS IN HEALTH INFORMATICS 
With increasing integration of technology into personal lives, health informatics 
has revolutionized how patients access and account for their own health information.  As 
defined by Gibbons et al, consumer health informatics (CHI) is any electronic tool, 
technology or system that allows consumers to obtain personal health information 
directly, including recommendations and data tracking, without the immediate interaction 
with a healthcare professional (Gibbons et al. 2009). CHI can be used in conjunction with 
a healthcare professional, but does not necessitate their participation to provide the 
information. Mobile health applications, for example, are a type of CHI tool that has 
paved the way for accessibility and ease in self-tracking health information. Benefits of 
these mobile applications include encouraging patients to be proactive about personal 
health, and consciously monitor bodily changes. Additionally, information recorded by 
patients can increase quality of care during doctor-patient visits by providing 
professionals with more complete patient histories. Mobile applications include features 
such as patient education, reminders, and real time data on patient’s health conditions to 
assist with disease management. “In a recent WHO Global Health Survey, 60% of high-
income countries and 30% of low and middle-income countries admitted using Short 
Message Service (SMS) messages and other mobile health communications tools for 
improving treatment compliance” (Abaidoo and Larweh 2014).  With this new 
developing tool, patients take on the role of being a key member to the care team.  
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UTILITY AND MONITORING OF MENSTRUAL CYCLE CHARACTERISTICS 
Variability of Menstrual Cycle Lengths in Existing Studies  
 As part of puberty, regular cycles are key to fertility and uterine health. Patients 
are often asked about the last date of their period and menstrual cycle lengths. Menstrual 
cycle lengths can then be used as a predictor of reproductive function (American 
Academy of Pediatrics Committee on Adolescence et al. 2006).  Reported irregular 
bleeding patterns could point to endocrine dysfunction, uterine abnormality, diabetes, or 
cardiovascular disease (Dasharathy et al. 2012). However, multiple studies have shown 
that there are still many discrepancies between actual and self-reported cycles (Figure 1), 
and overall natural variation in menstrual cycle lengths. 
Figure 1. Variability in Reported Menstrual Cycle Lengths (Small, Manatunga, and 
Marcus 2007; Chiazze et al. 1968; Jukic et al. 2008) 
  
010
2030
4050
6070
80
21-25	days	 26-29	days 30-31	days 32-35	days 36-39	days 40+	days
Variability	in	Reported	Menstrual	Cycle	Lengths	
Validity	of	Self	Reported	Menstrual	Cycle	Length	(Small	et	al.	2007)OM	Study	(Unpublished)Length	and	Variability	of	Human	Menstrual	Cycle	(Chiazze	et	al.	1968)Accuracy	of	Reporting	Menstrual	Cycle	Length	(Jukic	et	al.	2008)
	3 
The accuracy of reported menstrual cycle lengths has been demonstrated to be 
close, but still moderately skewed when compared to observed menstrual cycle lengths 
(Jukic et al. 2008). Women ages 20-40 report the least variability in cycle length, but 
beyond this age range, there is much variability in the number reported (Steiner et al. 
2001).  A New York study found that 43% of women reported cycle lengths that were 
within 2 days of their actual cycle lengths, showing that there is large margin of error for 
the reported measurement (Small, Manatunga, and Marcus 2007). Menstrual cycle 
lengths have commonly been reported to be either 28 or 30 days, when the observed 
mean was 27 days. Possible reasons for the overestimation could be due to number 
preference as people assume their length of their cycle (Small, Manatunga, and Marcus 
2007). Factors such as marital status and desire for fertility may also affect how closely 
the patient monitors their own menstrual cycles. Married women and unmarried women 
who are sexually active are more likely to report accurate lengths compared to unmarried 
celibate women. Similarly, women with a history of infertility are more likely to closely 
follow their cycle lengths as opposed to women without this condition. Past studies have 
observed demographic, behavioral and reproductive characteristics that may have 
systematic effects on reporting menstrual cycle lengths, but sample sizes were too small 
to generalize to a larger population (Jukic et al. 2008).  
In addition to inaccurate accounts of cycle length when self-reporting,  
menstrual cycle variability depends on demographics, anovulation, and menstrual 
hormones. Various menstrual cycle characteristics differ, including length and bleeding 
patterns. The highest variation in menstrual flow was found in females post-menarche 
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and immediately before menopause. During anovulatory cycles, there is an observed 
shorter menses length. Also, higher FSH levels in the follicular phase (ranges 0.083-
0.202 mIU/mL) and progesterone (ranges 0.030-0.057 ng/mL) correlate with a higher 
menstrual flow (Dasharathy et al. 2012). Overall, older, married and parous women 
usually have heavier menstrual flow. Multiple studies have confirmed that even people 
who believe they have “regular” menstrual cycles will become variable cycle to cycle 
(Creinin, Keverline, and Meyn 2004).  
For PCOS patients, there is even more variance in menstrual cycles. Because of 
this lack of predictability, it is vital to objectively track one’s cycle through a more 
effective means. The studies in the past recorded menstrual patterns and cycle lengths 
through paper diaries, leaving much room for human error. However, with the 
development of a mobile menstrual application, PCOS patients can enter data about 
changes during their menstrual cycle simply and reliably.  
 
PCOS BACKGROUND 
 Polycystic Ovary Syndrome (PCOS), a complex endocrine condition, may be 
multifactorial, due to a combination of genetic, environmental, metabolic and hormonal 
imbalances. PCOS is an autosomal dominant disorder, but has also been found to be 
caused by inheritance of various oligogenic traits. Mutations in alleles affecting ovarian 
and adrenal steroidogenesis, gonadotropin regulation, and insulin action are responsible 
for the multiple PCOS phenotypes. Genetic predisposition in combination with exposure 
of excess androgen to the fetus may lead to an increased onset of PCOS (Sirmans and 
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Pate 2013) .  
 
Clinical Presentation  
 PCOS is typically characterized with hyperandrogenism, chronic anovulation, and 
enlarged polycystic ovaries. However, there is no single diagnostic criterion and it 
presents with a broad spectrum of phenotypes (Laven et al. 2002). Four different 
phenotypes have been recognized for individualized treatment. These include: 1) 
hyperandrogenism and chronic anovulation 2) hyperandrogenism and polycystic ovaries 
3) chronic anovulation and polycystic ovaries without hyperandrogenism 4) 
hyperandrogenism, chronic anovulation and polycystic ovaries (Amato et al. 2011). 
Symptoms may include hirsutism, obesity, and menstrual irregularities. Insulin resistance 
and excess luteinizing hormone are also commonly found. Patients with PCOS are at 
higher risk for type II diabetes and cardiovascular disease (D. A. Ehrmann et al. 1999). 
Likewise, features on a menstrual application catered towards these populations must at 
least include options to track weight changes, hirsutism, acne and menstrual irregularities. 
 
Managing PCOS Symptoms 
 For androgen related symptoms such as hirsutism, alopecia and acne, oral 
contraceptive pills are prescribed. Taking advantage of the negative feedback on the 
production of LH, the hormonal contraceptive will subsequently cause a decrease in 
androgens secreted. Metformin has also been commonly prescribed to increase insulin 
sensitivity and decrease circulating androgens.  
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 For menstrual irregularity, there is an increased risk for endometrial hyperplasia. 
To reduce this risk, combined hormonal contraceptives with estrogen and progestin are 
prescribed to inhibit endometrial proliferation (Group 2001).  
To treat infertility, randomized controlled trials comparing the effects metformin 
and clomiphene citrate have shown to be both successful in improving ovulation 
induction and live birth rates. A meta-analysis comparing the treatments showed that in 
study sample of women with BMI <30-32 kg/m2) pregnancy rates were 46.7% with 
metformin and 35.7% with clomiphene. Live birth rates were 30.4% with metformin and 
30.8% with clomiphene (Johnson 2011).   
In addition to medications, lifestyle changes must be made, which include  
following a recommended diet as well as focusing on exercise and weight loss. Hormonal 
imbalance in the hypothalamic-pituitary-ovarian axis causes the reproductive and 
metabolic abnormalities such as anovulation, hyperandrogenemia, and insulin resistance. 
Because these conditions are linked to chronic disease like metabolic syndrome, it is 
important to prescribe medical intervention early in order to see favorable effects (Crete 
and Adamshick 2011). 
 A combined treatment will show the most effective results, especially when 
PCOS is considered a dysmetabolic syndrome. Treatment resolves symptoms short-term, 
and allows systemic regulation long term. A study with obese teenage girls ages 15-18, 
found that a 6 month treatment with metformin restored menstrual regularity in 50% of 
patients (Petta et al. 2017). Menstrual periods become regular and ovulatory, while there 
were significant reductions in testosterone, and androstenedione. Hirsutism and acne 
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decreased after 6 months, and BMI decreased to normal ranges. Even 6 months after the 
treatment, menstrual periods continued to be normal and BMI stayed within normal 
ranges (Petta et al. 2017). 
With the observable success of treatment, it is very necessary to evaluate all 
women with hyperandrogenism, menstrual irregularity, and polycystic ovaries for PCOS. 
Diagnosing early and beginning treatment will decrease frustration over lack of control of 
weight and hirsutism, and reduce confusion about the risk factors or implications of the 
diagnosis. Symptom management and understanding the diagnosis will allow patients to 
achieve balance and well-being in their lives (Crete and Adamshick 2011). Menstrual 
tracking applications play an important part in the role of increasing detection and 
tracking changes in symptoms. Women can use a menstrual tracking application to regain 
control of their lives and manage the disorder comfortably.  
 
BENEFITS OF MENSTRUAL TRACKING APPLICATIONS  
 With the recent growth in mobile applications, menstrual tracking applications 
have taken the forefront in being a personal informatics tool. Menstrual tracking 
applications views ovulation and menstruation health from a holistic standpoint, 
encompassing features to track a multitude of symptoms, cycle variances, and predicting 
future periods. Major uses of menstrual health trackers include being aware of exactly 
which date periods will arrive, fertility/becoming pregnant, understanding bodily 
changes, and being more informed when speaking to health professionals. The ease of 
entry into mobile applications increases accuracy in reporting symptoms as opposed to 
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recall by memory. Tracking menstrual cycle data allows women to record the live 
experience during their cycles, and later make better-informed health decisions. Most 
women do not have a means of accurately recalling their last menses without a recording 
tool. Through a survey done by Epstein et al., 47% of participants used menstrual 
tracking applications, being the most common method of tracking compared to all other 
methods (Epstein et al. 2017). The convenience and functionality of menstrual tracking 
applications has harnessed increasing popularity of their usage. This popularity shows 
promise in using menstrual tracking applications to increase patient involvement, 
treatment management and even data collection for research purposes. 
 
MONITORING PCOS IN MENSTRUAL TRACKING APPLICATIONS 
PCOS, one of the most common reproductive disorders has been highly 
underdiagnosed, when comparing prevalence rates to community samples	(Crete and 
Adamshick 2011). Currently, women ages 20-24 years old have the highest incidence as 
well as women living in deprived areas. With these underdiagnoses, many women have 
not started treatment for symptoms such as hirsutism, alopecia and acne, and are not able 
to reduce metabolic risks or risk for cardiovascular disease.	Although	there	is	no	
standard treatment for PCOS, starting on a treatment regime has had high success in 
managing the symptoms and increasing the quality of life for women (Ding et al. 2016). 
For PCOS patients, the ideal menstrual tracking application would allow 
consistent tracking even with irregular cycles as well as reporting of specific symptoms 
such as weight changes, acne fluctuations, and hair growth. Although the exact dates of 
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menstruation may not be predicted, menstrual tracking applications would provide a tool 
to recognize patterns, and better manage the condition. 
 
DEFINING APPROPRIATE MENSTRUAL TRACKING APPLICATIONS 
What areas of health monitoring does a menstrual tracking application address?  
Menstrual cycle characteristics include regularity, cycle length, duration and 
intensity of menses. Lifestyle changes or habits may lead to irregular patterns and 
disruption of the hypothalamic-pituitary-ovarian axis. Usage of a menstrual tracking 
application will address all menstrual characteristics, giving the option to track each 
category with convenience. Menstrual tracking applications can include options to track 
all menstrual characteristics and related areas of health that affect the reproductive 
hormonal axis. This includes sleep patterns, sexual activity, energy levels, digestion, 
cravings, skin, weight, body temperature, and stress levels. Menstrual irregularity has 
been correlated to patients developing a higher risk for type 2 diabetes, cardiovascular 
disease, osteoporosis, endometrial and breast cancer (Hahn et al. 2013). Therefore, it is 
important to track and view associations from all mental and physiological changes to 
prevent co-occurrences of other conditions.  
This is especially important in patients with PCOS, who commonly suffer from 
fluctuations with symptoms related to reproductive endocrine axis. For example, there is 
a higher prevalence of women with PCOS who have obstructive sleep apnea compared to 
men (David A. Ehrmann 2012). Sexual drive in adolescents with PCOS is greatly 
decreased (Trent et al. 2003). Binge eating behaviors have a positive correlation in obese 
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and overweight women with PCOS (Jeanes et al. 2017). Having androgen excess has also 
been correlated to negative moods, putting PCOS patients at higher risk for depression 
(Weiner, Primeau, and Ehrmann 2004). Ideally, PCOS patients will be able to monitor all 
areas of health through menstrual tracker applications and protect themselves from 
exacerbation of symptoms.  
 
Challenges with Current Menstrual Tracking Applications   
With the recent spike in application development, many problems have risen in 
deciding which application is all encompassing, accurate and most effective for both 
patients and physicians. The most pressing issue is a phenomenon called application 
overload.  For both parties, the huge number of applications available has actually made 
it more difficult to choose which specific application would fit personal needs.  
Additionally, the two operating systems, iOS versus Android, hold different menstrual 
applications available for download, which limits options for users. Other issues include 
failure to support gender and sexual minorities through the design of applications 
(Epstein et al. 2017). This may include color, theme, language, and lack of inclusivity of 
multiple genders. Finally, many applications fail to address patients who have 
reproductive disorders, including Polycystic Ovary Syndrome, which affects 15-20% of 
women (Sirmans and Pate 2013).  For patients with menstrual irregularity, the algorithm 
of current applications is unable to predict when the next period will arrive. The 
substantial number of patients who suffer from such disorders are unable to accurately 
track their cycle.  The solution to these issues would be to identify which applications are 
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considered high quality applications and assess which areas need improvement. In the 
past, peer-review has been the only method to compare applications.  Although peer-
review allowed for a thorough analysis of each application, the process is too slow, and 
by the time one review of applications is complete, new applications have already been 
developed (Lunde et al. 2017). More recently, an APPLICATIONS Scoring System has 
been developed to objectively rank available applications (Moglia et al. 2016). Despite its 
inability to include features for populations with reproductive disorders, it is currently the 
only available assessment tool.  
 
Evaluation Method for Menstrual Tracking Applications  
 The APPLICATIONS scoring system identifies whether or not certain features or 
function are included in a menstrual tracking application. Current components include 
conception, contraception, fertility medications, password protection, professional 
involvement, literature cited, in-app purchases, connectivity, advertisements, technical 
support, interplatform availability, navigation ease, subjective presentation. There is an 
“other” category which includes social media, medical disclaimer, health education, data 
backup, email or export data, Spanish language, custom reminder, pregnancy mode, track 
flow amount, track symptoms, track intercourse, alert next menses, alert for fertility, 
average cycle length (Moglia et al. 2016). Apps are given either 0 or 1 point for each 
category and apps with a higher total score are considered to be the more comprehensive 
apps. Although the scoring system includes these categories, it is a superficial assessment 
on quality of the application. There are no set guidelines to what constitutes 0 or 1 point. 
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For example, apps may include tracking symptoms, but this could vary from ovulation 
pain, breast tenderness, or increased discharge. Through this scoring system, an app could 
include ovulation pain and would qualify for 1 point in the “tracking symptoms” 
category. Ovulation pain is not the only symptom involved in menstruation, thus scoring 
1 point in this category would be inaccurate. Appropriate scoring would need specific and 
expanded guidelines to include categories such as weight changes, hirsutism, acne, and 
menstrual irregularity to cater towards diverse populations, like PCOS patients. Although 
it is the only existing scoring system, if only offers a binary assessment and no threshold 
for defining a quality application.  
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Specific Aims 
 In order to demonstrate a need to develop a comprehensive menstrual tracker 
application effective for all women including those with PCOS, we will: 
1. Determine the most used method of menstrual tracking  
1a. Determine the relationships between demographic factors and 
menstrual tracking methods  
1b. Determine variability of menstrual tracking application preference by 
age 
2. Determine functionality of top 10 menstrual tracking applications and inclusion of 
PCOS-specific features  
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METHODS  
 
(Specific Aim #1) DETERMINING THE MOST USED METHOD OF MENSTRUAL 
TRACKING   
 In order to evaluate menstrual tracking usage in a more representative cohort, data 
from the Ovulation and Menstruation Health: a PCOS Cohort Pilot Study was used.  The 
Ovulation and Menstruation Health Study ran from August 2016 to August 2018 with a 
3-month window for patient recruitment. Because most studies of PCOS have included 
homogenous, ethnically-white groups, this study aims to create a more diverse cohort in 
order to study the risks and lifestyle characteristics of people with PCOS. The study uses 
an online platform, which includes a consent form and survey module through REDCAP. 
Participants recruited were ages 18-45, not pregnant, and have had no radiation or 
chemotherapy. Within 1 month, the recruitment target of enrolled participants was 
reached with 50% more diversity in the pilot compared to existing large cohorts.  In total, 
346 women were enrolled, 288 were eligible, 221 started the survey and 195 completed 
the survey. The survey includes questions of menstrual irregularity, androgen excess 
(hirsutism, acne, and biochemical), polycystic ovaries on ultrasound, past diagnosis of 
PCOS or suspected PCOS to ascertain both unaffected and affected women.  The survey 
also includes questions on demographics, health history, obstetric history, family history, 
social history and limited questions on diet and lifestyle. By including these questions for 
all participants, the underdiagnosis of PCOS can be assessed after comparison of data 
between suspected PCOS and approved patient data at Boston Medical Center.  
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.  
Recruitment strategies included physical advertisement materials, in-clinic 
recruitment and social media advertising. Informational study posters and flyers were 
disseminated throughout Boston Medical Center and community bulletin boards 
throughout Boston. In-clinic recruitment required training research assistants to obtain 
consent from and recruit patients at the Boston Medical Center. Research assistants 
coordinated with OB/GYN departments at Boston Medical Center, and facilitated patient 
recruitment during waiting times. Additional in-person recruitment included tabling at the 
Boston’s Women’s Market, where participants were able to approach the booth, complete 
the consent form and fill out the survey on their own time. Social media advertisement 
included publicizing through the official Ovulation and Menstruation Health Facebook 
Page, and sharing the study link on personal Facebook pages. Through these main 
avenues of publicity, the study link was able to reach participants all over the United 
States. A large following was built through the social media advertisement and 
participants of the OM study came from multiple states including, Massachusetts, 
Missouri and California. For a larger global dissemination, the OM study team has 
reached out to larger corporations interested in menstrual health, like DivaCup to partner 
and recruit from established networks. DivaCup, a company that specializes in creating 
menstrual cups, has supported the OM study by including the OM study link in their 
newsletter, sent to other researchers and product users all over the world.  
 Data from the OM Study Pilot was used to study demographic variables, 
menstrual tracking methods, and usage from PCOS diagnosed patients. To look at the 
demographic variables, answers were collected from “Section VI – Menstrual Cycle”, 
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and questions are follows: “Do you keep track of your menstrual cycle?”, “What do you 
use to track your menstrual cycle?”, “Please write the name of the application you use”, 
“Please describe what else you use to track your menstrual cycle”. Different tracking 
methods include use of a mobile application, paper calendar, digital calendar, birth 
control, memory, or none. Thirdly, data from PCOS patients is collected by asking “enter 
in question about pcos dx).  Additionally, the top 10 applications were isolated to 
compare which applications were most popular among different age groups.  
  
Statistical Analyses  
Descriptive statistics were run on SPSS Version 25.0. Chi-squared values, 
Cramer’s V, and odds-ratios were calculated for all measures in the demographic 
analyses. To calculate the odds-ratio for PCOS Status and Perception of Health, 
categories fair/poor were collapsed together as well as good/very good/excellent. PCOS 
status is collapsed for both physician and self-diagnoses. For the analysis of 
race/ethnicity, all races/ethnicities excluding “White” were collapsed into “Other”.  
 
(Specific Aim #2) DETERMINING FUNCTIONALITY OF TOP 10 MENSTRUAL 
TRACKING APPLICATIONS AND INCLUSION OF PCOS-SPECIFIC FEATURES 
Compiling Current & Popular Mobile Menstrual Applications 
 
A complete list of the top 10 mobile menstrual applications was generated through an 
online search through popular women’s online magazines including Refinery29 and 
Daily Dot. A second search was done through the Apple Store and Google Play for the 
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top 10 menstrual tracking applications with the most users and highest ratings. Menstrual 
tracking applications were then ranked by user popularity, the number installs and order 
of highest ratings. These included Clue, Period Calendar, Period Tracker, Flo, My 
Calendar, Period Tracker by Amila, Glow, Eve, Pink Pad, SpotOn. Menstrual tracking 
applications were then downloaded onto a mobile iPhone and iPad to browse 
functionality on both interfaces. All personal health information on menstruation, 
symptoms, and informatics were loaded onto all applications with consistent information 
for tracking. 
 
Evaluating Functionality of Menstrual Tracking Applications  
 With consistent health information entered into every application, algorithm and 
differences in functionality of each application could be compared. Mirroring the 
APPLICATIONS Scoring system (Moglia et al. 2016), each application was evaluated 
for functionality through multiple categories which include: race/ethnicity, hours of sleep, 
language, height/weight, period length, cycle length, contraceptive type, abdominal 
cramps, breast symptoms, cervical symptoms, moodiness, stress, intercourse/libido, 
fertility window, medications, acne, hair growth, infertility, reproductive conditions, 
education inclusion, navigation/usability, gender neutrality, aesthetic. For each category, 
there are defined guidelines to what constitutes as a 1 or 0 in order to objectively score in 
each category. A total score and PCOS score are given for each application to assess 
complete functionality, and applicability to PCOS-specific symptoms.  
Definitions for each category are as follows: 
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• Race/Ethnicity – Users have the option to enter their own race and ethnicity. 
Race/Ethnicity must include all options recognized on the Census Bureau.  
• Hours of Sleep – Users have the option to enter in their hours of sleep daily, 
or the application is synced towards tracking sleep cycles by accessory 
appliances (i.e. Apple Watch, FitBit, Sleep Cycle Applications) 
• Language – Applications are available in multiple languages.  
• Period Length – Users can enter in the start of the period date until the end of 
the period date monthly.  
• Bleeding – Users can enter in the amount of flow, which can vary from light, 
medium to heavy.  
• Collection Method – User can enter in their collection method (i.e. sanitary 
napkins, tampons, menstrual cups) 
• Cycle Length – Application will generate cycle length according to entered 
period dates. 
• Contraceptive Type – Application includes option to enter in all contraceptive 
types, including birth control pills, type of birth control pills, reminder for 
birth control pills, birth control patch, dates of birth control patch usage, birth 
control implant, birth control shot, birth control vaginal ring, condoms, IUD, 
IUD checks and removal. 
• Abdominal Cramp – User has the option to enter in severity of cramping to 
mild, medium, extreme every day throughout cycle.  
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• Breast Symptoms – User has the option to enter breast tenderness and 
soreness. Option for lumpy breasts should be made available.  
• Cervical symptoms – User has the option to enter in changes in cervix. This 
includes cervical discharge ranging from differences in consistency, and 
cervical pain (mild, medium, extreme).  
• Moodiness – User has the option to track changes in mood including increased 
irritability, sensitivity, sadness, pre-menstrual stress, and positive emotions.  
• Stress – User has the option to track stress 
• Intercourse/Libido– User has the option to track which days intercourse 
occurred, whether it was painful, and if protection was used. Libido should 
have options for tracking levels of sex drive.   
• Social – User has the option to enter sociability levels (i.e. low, medium, high) 
• Exercise – User has the option to enter the amount of daily exercise 
• Ailment/Sickness – User has the option to enter in data according to sickness. 
• Fertility Window – According to entered period dates, fertility window should 
be marked for high, medium and low chance. 
• Medications – An option to enter in medications, not including birth control 
should be available.  
• Reproductive Conditions – Option for various reproductive conditions should 
be available to be entered. This includes Polycystic Ovary Syndrome but this 
field can be left open for the user to enter. 
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• Education – Application should have defined terms for each symptom and 
category for user to understand and accurately enter in data.  
• Navigation/Usability – Ease of navigation and usability is rated on 
organization, and how quickly the user is able to understand and utilize all 
functions of the application.  
• Gender Neutrality – Application should not be limited to “pink” or 
“traditionally feminine” colors or designs.  
• Aesthetic – Design of application should be pleasing and attracts user to return 
to the interface.  
PCOS-Specific Categories: 
• Weight – Users can track weight or have the option to sync data with others 
applications that track this data. 
• Acne – Changes in skin should be tracked, including mild, moderate to severe 
acne.  
• Hair Growth – Option for mild, moderate to extreme hair growth with pictures 
or a mode for comparison for users to gauge. An alternative could also be an 
option that asks how often hair must be removed.  
• Infertility – Users who are aware of their infertility should have an option to 
enter in this data, and the application will alert user of most fertile dates or if 
fertility changes according to patterns of cervical mucus.  
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RESULTS 
 
 
 (Specific Aim #1) DETERMINING THE MOST USED METHOD OF MENSTRUAL 
TRACKING   
 To evaluate the usage of different menstrual tracking methods, demographics from the 
OM Health study were analyzed. Among 225 participants, 8 used a menstrual tracking 
application, 21 tracked by hand on a paper calendar, 7 used a digital calendar, 4 track by 
memory and 19 track through birth control pills, and 20 don’t use any form of tracking. 
Those who track by birth control rely on a consistent schedule of taking pills, and 
expecting a period during placebo weeks.  
Table 1. Overall Usage of Menstrual Tracking Methods  
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Total Participants 
(n = 225) 
88 
(39.1%) 
21 (9.3%) 7 (3.1%) 4 
(1.78%) 
19 
(8.4%) 
20 (8.8%) 
 
PCOS Status vs. Preference of Menstrual Tracking Method 
Out of the 225 participants, 33 received a PCOS diagnosis from a physician and 16 were 
self-diagnosed. Seventeen of the physician diagnosed PCOS patients use a phone 
application, 3 use paper calendar, 1 uses digital calendar, 2 use birth control and 9 don’t 
have any method of tracking. For those with a self diagnosis of PCOS, 8 use a phone 
application, none use paper calendar/digital calendar or memory, 4 use birth control, and 
4 don’t use any method. For people without a PCOS diagnosis, 63 use a phone 
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application, 18 use paper calendar, 6 use digital calendar, 4 rely on memory, 13 rely on 
birth control, and 4 don’t have any methods of tracking.  
Table 2. PCOS Status Versus Preference of Menstrual Tracking Method in OM 
Health Study 
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
PCOS Dx Status       
PCOS: Dr Dx  
(n =33) 
17(51.5%) 3 (9.0%) 1 (3%) 0 2(6%) 9 (27.2%) 
PCOS: Self Dx 
(n =16) 
8 (50%) 0 0 0 4 (25%) 4 (25%) 
No PCOS  
(n = 176) 
63(35.7%) 18(10.2%) 6 (3.4%) 4(2.2%) 13(7.3%) 71(40.3%) 
 
There was no statistically significant association between PCOS Status and 
preference for method of tracking menstrual cycle c2 (10) = 3.1246, p = 0.0771. There is 
a very weak association between PCOS Status and preference for menstrual tracking 
method if the null hypothesis can be rejected., Cramer’s V= 0.118. 
 
 
 
 
 
	23 
Figure 2. PCOS Status Versus Preference of Menstrual Tracking Method 
 
After collapsing the physician and self-diagnosed PCOS patients into one category 
(Table X), there are 49 PCOS patients and 176 non PCOS patients. 36 PCOS patients use 
some form of tracking method, and 13 do not use any method. 105 people without a 
PCOS diagnosis use some form of tracking method, and 71 don’t use any tracking 
method  
Table 3. Prevalence Ratio of PCOS Dx Versus Usage of Tracking Method  
 Yes Tracking Method No Tracking Method 
PCOS Dx (Dr. + Self)  36 13 
No PCOS  105 71 
. 
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 The prevalence ratio of the amount of PCOS Diagnosed patients who use a 
tracking method was calculated to be 1.8725 with 95% Confidence Interval (93% - 
380%). There is a high probability of patients with PCOS that will use a tracking method.  
PCOS Versus Perception of Health  
Out of 49 PCOS diagnosed patients (both physician and self), 11 perceived their health as 
fair/poor, and 38 view their health was excellent/very good/good. Out of everyone 
without a PCOS diagnosis, 14 perceived their health to be fair/poor and 162 believe their 
health is in excellent/very good/good condition. 
Table 4. PCOS Versus Perception of Health 
 Fair/Poor Excellent/Very Good/Good 
PCOS Dx (Dr. + Self) 11 38 
No PCOS  14 162 
 
The prevalence ratio of the amount of PCOS Diagnosed patients who perceive their 
health as poor is 3.35 with a 95% Confidence Interval (141% - 796%). There is a high 
probability of patients who perceive their health as fair/poor. 
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(Specific Aim #2a) Determining the relationships between demographic factors and 
menstrual tracking methods  
Race/Ethnicity Versus Preference of Tracking Method 
Out of 155 White participants, there were 61 who used phone applications, 15 use paper 
calendars, 4 use digital calendar, 2 by memory, 14 rely on birth control and 58 who do 
not use any form of tracking. There were 79 participants in “Other” race/ethnicities. 32 
use phone application, 7 use paper calendars, 3 use digital calendars, 3 rely on memory, 5 
rely on birth control and 28 have no tracking method at all. 
Table 5. Race/Ethnicity Versus Preference of Tracking Method from OM Health 
Study  
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Race/Ethnicity       
      White (n=155) 61(39.3%) 15(9.6%) 4(2.4%) 2(1.2%) 14(9%) 58(37.4%) 
      Other (n=79) 32(40.5%) 7(8.8%) 3(3.7%) 3(3.7%) 5(6.3%) 28(35.4%) 
For race versus preference for tracking method, a chi square test for association 
was conducted. There was no statistically significant association between race and 
preference for method of tracking menstrual cycle c2 (5) = 2.382, p = 0.794. There is a 
very weak association between race and preference for menstrual tracking method if the 
null hypothesis can be rejected., Cramer’s V= 0.101.  
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Figure 3. Race versus Preference of Tracking Method 
 
 
Immigration Status Versus Preference of Tracking Method  
Out of the 194 participants who were born in the United States (U.S.), 79 use phone 
applications, 17 use paper calendars, 4 use digital calendar, 4 rely on memory, 19 use 
birth control, and 69 use no tracking method. For the 40 participants born outside of the 
U.S., 14 use a phone application, 5 use paper calendars, 3 use digital calendar, 1 relied on 
memory, and 17 do not track at all.  
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Table 6. Immigration Status vs. Preference of Tracking Method from OM Health 
Study 
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Immigrant status       
US born 
(n=194) 
79(40.7%) 17(8.7%) 4(2%) 4(2%) 19(9.7%) 69(35.5%) 
Not US  
born(n=40) 
14(35%) 5(12.5%) 3(7.5%) 1(2.5%)  17(42.5%) 
 
  There was no statistically significant association between race and preference for 
method of tracking menstrual cycle c2 (5) = 8.365, p = 0.137. There is a very weak 
association between immigration status and preference for menstrual tracking method if 
the null hypothesis can be rejected., Cramer’s V= 0.190.  
Figure 4. Immigration Status vs. Menstrual Tracking Method 
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Education Level vs. Preference of Tracking Method  
Out of the 17 participants who graduated high school or completed GED, 7 use phone 
applications, 2 use paper calendars, 1 use digital calendar, and 7 don’t use any method of 
tracking. From the 34 who received some college or 2-year degree, 14 use a phone 
application, 4 use paper calendars, 1 uses memory, 1 uses birth control, and 14 don’t use 
any method of tracking. In the 4-year college degree category, there are 86 total 
participants. 36 of these people use a phone application, 9 use paper calendars, 1 uses 
digital calendar, 1 uses memory, 8 use birth control, and 30 do not use any method of 
tracking at all. Out of the 96 participants who received more than a 4-year college degree, 
36 use a phone application, 7 use paper calendar, 5 use digital calendar, 3 rely on 
memory, 10 use birth control, and 34 do not have any method of tracking.  
Table 7. Education Level versus Preference of Tracking Method from OM Health 
Study 
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Education       
High school 
graduate or 
GED(total = 17) 
7(41.1%) 2(11.7%) 1(5.8%)   7(41.1%) 
Some college or 
2-year 
degree(total=34) 
14(41.1%) 4(11.7%)  1(2.9%) 1(2.9%) 14(41.1%) 
4-year college 
graduate 
(total=86) 
36(41.8%) 9(10.4%) 1(1.1%) 1(1.1%) 8(9.3%) 30(34.8%) 
More than 4-
year college 
degree 
(total=96) 
36(37.5%) 7(7.2%) 5(5.1%) 3(3.1%) 10(10.4%) 34(35.4%) 
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There was no statistically significant association between race and preference for 
method of tracking menstrual cycle c2 (5) = 10.015, p = 0.819. There is a very weak 
association between education level and preference for menstrual tracking method if the 
null hypothesis can be rejected., Cramer’s V= 0.120.  
 
Figure 5. Education vs. Menstrual Tracking Method  
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Income versus Preference of Menstrual Tracking Method 
Out of the 25 participants with income level below $15,000, 9 use a phone 
application, 5 use paper calendars, 2 use digital calendar, 2 rely on birth control and 7 use 
no method of tracking. For the 27 participants in the income bracket $15,000 - $24,999, 8 
use a phone application, 4 use paper calendars, 1 relies on memory, 2 use birth control, 
and 12 do not have any method of tracking. In the income bracket $25,000 - $49,999, 
there are a total of 60 participants. 23 of people within this bracket use a phone 
application, 6 use paper calendars, 2 rely on memory, 6 use birth control and 23 do not 
have any method of tracking at all. Out of 39 participants in the $50,000 - $74,999 
income bracket, 18 use phone application, 4 use paper calendars, 1 uses digital calendar, 
2 use birth control and 14 do not use any tracking method. Out of the 15 participants in 
the $75,000 - $99,999 income bracket, 8 use phone application and 7 do not use any 
method. In the $100,000 - $124,999 bracket, 5 use phone application, 1 uses digital 
calendar, 2 use birth control and 2 do not use any tracking method. In the bracket 
$125,000 - $149,999, 2 use phone applications, 1 uses paper calendar, and 1 doesn’t use 
any tracking method. In income bracket $150,000 - $199,999 (n = 7), 1 uses digital 
calendar, 1 uses memory, 2 use birth control, and 3 do not use any method. In bracket  
>$200,000 (n=14), 6 use phone application, 1 uses paper calendar, 1 uses digital 
calendar, and 5 do not use any tracking method. In bracket “Prefer not to answer/Don’t 
know” (n=15), 6 use phone application, 1 uses memory, 3 use birth control, and 5 do not 
use any tracking method. 
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Table 8. Income versus Preference of Menstrual Tracking Method from OM Health 
Study 
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Income       
Below $15,000 
(total=25) 
9(36%) 5(20%) 2(8%)  2(8%) 7(28%) 
$15,000 – $24,999 
(total=27) 
8(29.6%) 4(14.8%)  1(3.7%) 2(7.4%) 12(44.4%) 
$25,000 – $49,999 
(total=60) 
23(38.3%) 6(10%)  2(3.3%) 6(10%) 23(38.3%) 
$50,000 – $74,999 
(total=39) 
18(46.1%) 4(10.2%) 1(2.5%)  2(5.1%) 14(35.8%) 
$75,000 – $99,999 
(total=15) 
8 (53.3%)     7 (46.6%) 
$100,000 – $124,999 
(total=10) 
5 (50%)  1 (10%)  2 (20%) 2 (20%) 
$125,000 – $149,999  
(total=4) 
2 (50%) 1 (25%)    1 (25%) 
$150,000 – $199,999  
(total=7) 
  1(14.2%) 1(14.2%) 2(28.5%) 3(42.8%) 
≥$200,000  
(total = 14) 
6(42.8%) 1(7.1%) 1(7.1%)   5(35.7%) 
Prefer not to 
answer/Don’t 
know (total=15) 
6(40%)   1(6.6%) 3(20%) 5(33.3%) 
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 There was no statistically significant association between income and preference 
for method of tracking menstrual cycle c2 (40) = 45.011, p = 0.270. There is a weak 
association between education level and preference for menstrual tracking method if the 
null hypothesis can be rejected., Cramer’s V= 0.211.  
Figure 6. Income Level vs. Menstrual Tracking Method 
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Age versus Preference of Menstrual Tracking Method 
In age bracket 18-29 (n=171), 68 participants use phone applications, 15 use paper 
calendars, 2 use digital calendar, 4 rely on memory, 16 use birth control and 65 do not 
have any method of tracking. In age bracket 30-39 (n=49), 18 participants use phone 
application, 4 use paper calendars, 1 uses digital calendar, 1 relies on memory, 3 use birth 
control and 19 do not have any method of tracking. In bracket 40-49 (n=13), 6 use phone 
application, 3 use paper calendars, 2 uses digital calendar, and 2 do not use any tracking 
method. In bracket 50-59 (n=1), 1 person uses phone applications. 
Table 9. Age versus Preference of Menstrual Tracking Method in OM Health Study 
 Phone 
App 
Paper 
Calendar 
Digital 
Calendar 
Memory Birth 
Control 
None 
Age       
       18-29 (=171) 68 
(39.7%) 
15 
(8.7%) 
2 (1.1%) 4(2.3%) 16(9.3%) 65 (38%) 
       30-39 (=49) 18(36.7%) 4(8.1%) 1(2%) 1(2%) 3(6.1%) 19(38.7%) 
       40-49 (=13) 6(46.1%) 3(23%) 2(15.3%)   2(15.3%) 
       50-59(=1) 1 (100%)      
 
 There was no statistically significant association between age and preference for 
method of tracking menstrual cycle c2 (15) = 15.865, p = 0.391. There is a very weak 
association between age and preference for menstrual tracking method if the null 
hypothesis can be rejected., Cramer’s V= 0.146. 
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Figure 7. Age versus Menstrual Tracking Method 
 
(Specific Aim #1b) Determining variability of menstrual tracking application 
preference by age 
When evaluating the age vs. menstrual application popularity, the OM Pilot study 
data was analyzed for which application was popular among age brackets. Among all 
ages, Clue proved to be the most popular with 26 users then the second most popular is 
Period (P) Tracker with 20 users. Within the age brackets, groups 18-29 had the highest 
percentage of users for Clue, 30.8%, and 20.5% for P tracker. The percentage of users 
ages 30-39 decreases to 25% with Clue and 0% in age brackets 40+. 
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Table 10. Usage of Menstrual Tracking Applications by Age Category 
 Clue Eve Flo Glow My 
Calendar 
P 
Tracker 
Pink 
Pad 
SpotOn Other 
Age          
18-29 
(n=68) 
21 
(30.8%) 
3 
(4.4%) 
6 
(8.8%) 
4 
(5.8%) 
1 
(1.4%) 
14 
(20.5%) 
3 
(4.4%) 
8 
(11.7%) 
8  
30-39 
(n=20) 
5 (25%) 0 0 0 2 (10%) 5 (25%) 1 (5%) 0 7 
40-49 
(n =7) 
0 1 
(14.2%) 
0 0 1 
(14.2%) 
1 
(14.2%) 
0 0 4 
50-59 
(n =1) 
0 0 0 0 0 0 0 0 1 
Total  26 4 6 4 4 20 4 8 20 
A statistically significant association between age and preference for menstrual 
application was found, c2 (8) = 46.326, p = 0.001 There is a moderately strong 
association between age and preference for menstrual application type, Cramer’s V= 
0.606.  
Figure 8 Age versus Application Popularity  
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(Specific Aim #2) DETERMINING FUNCTIONALITY OF TOP 10 MENSTRUAL 
TRACKING APPLICATIONS AND INCLUSION OF PCOS-SPECIFIC FEATURES 
 The top 10 menstrual applications were compiled through a search on popular 
women’s magazines and the iOS Apple Store. Five of the most popular women’s 
magazines were chosen, which includes Refinery 29, Daily Dot, The Next Web, 
Women’s Health Magazine, and Shape. The top 10 for this study was chosen by looking 
at the highest rated apps on the Apple Store, and the most downloaded apps.   
Table 11. Compiled Top 10 Menstrual Applications  Apple	iOS	 5	Women’s	Magazines	
Clue	 Clue	Period	Calendar	 Period	Calendar	Flo	 Flo	My	Calendar	 Pink	Pad	Glow	Fertility	 Glow	Fertility	Period	Tracker	 Period	Tracker	Eve	 Eve	Pink	Pad	 PinkPad	SpotOn	 Natural	Cycles	
 
The 10 applications were assessed for completion and features that track 
symptoms of PCOS, which includes tracking weight, acne, hirsutism and infertility. 
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Table 12. Functionality of Top 10 Menstrual Tracking Applications with PCOS-
Specific Features 
 Clue Period 
Calendar 
Flo My 
Calendar 
Glow 
Fertility 
Period 
Tracker 
  
Eve 
Pink 
Pad 
Spot 
On 
Race/Ethnicity 0 0 0 0 0 0 0 0 0 
Hrs of Sleep 1 0 1 0 1 0 0 0 0 
Language 1 0 1 0 0 0 1 0 0 
Period Length 1 1 1 1 1 1 1 1 1 
Bleeding  1 1 1 1 1 1 1 1 1 
Collection Method 1 0 0 0 0 0 0 0 0 
Cycle Length 1 1 1 1 1 1 1 1 1 
Contraceptive Type 1 0 0 0 1 0 1 0 1 
Abdominal Cramps 1 1 1 1 1 1 1 1 1 
Breast Symptoms 1 1 1 1 1 1 1 1 1 
Cervical Symptoms 1 1 1 1 1 0 1 1 0 
Mood 1 1 1 0 1 1 1 1 1 
Stress 1 1 1 0 1 1 1 1 1 
Intercourse 1 1 1 1 1 1 1 1 1 
Social  1 1 0 0 0 0 0 0 0 
Exercise 1 0 1 0 1 0 1 0 1 
Ailment 1 1 1 1 1 0 1 0 1 
Fertility Window 1 1 1 1 1 1 1 1 1 
Medications 1 1 1 1 1 1 0 0 0 
Reproductive 
Conditions 
0 0 0 0 0 0 0 0 0 
Education 1 0 1 0 0 0 1 0 1 
Navigation/Usability 1 1 1 1 1 1 1 1 1 
Gender Neutrality 1 1 1 0 1 1 1 1 1 
Aesthetic  1 1 1 0 1 1 1 1 1 
Forum 0 1 1 0 1 1 1 1 0 
Weight 1 1 1 1 1 0 1 1 0 
Acne 1 1 1 1 1 1 1 1 1 
Hair Growth 0 0 0 0 0 0 0 0 0 
Infertility 0 0 0 0 0 0 0 0 0 
PCOS Score  2 2 2 2 2 1 2 2 1 
Completion Score 24 19 22 13 21 15 21 16 15 
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When comparing functionality of menstrual applications of the 10 most popular 
and highly rated applications, Clue scored the highest with a completion score of 24, 
while SpotOn scored 15 (Table 12). Period Tracker and SpotOn had a PCOS Score of 1 
out of 4. All other applications had a PCOS Score of 2. All applications but Period 
Tracker and SpotOn tracked weight changes. All applications scored 1 point in tracking 
acne changes, but no applications scored 1 point in other areas of PCOS symptoms (hair 
growth and infertility). All applications scored 1 point in tracking bleeding, cycle length, 
abdominal cramps, breast symptoms, intercourse, and fertility window. No applications 
included options to track any other reproductive conditions. For other features non-
related to PCOS, Clue was the only application that had options to track collection 
method. All except My Calendar tracked Mood and Stress. Clue and Period Calendar 
tracked sociability.  All except Eve, PinkPad and SpotOn had the option to enter in other 
medications. All applications scored 1 point in navigation and usability. All applications 
except for My Calendar scored 1 point for Gender Neutrality and Aesthetic. Clue, My 
Calendar and SpotOn are the only applications that did not score 1 point in having a 
forum.  Only 4/10 applications evaluated had educational components on their 
application for the user to understand. No applications had the option of entering in 
race/ethnicity.  
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DISCUSSION 
With the increase in a variety of consumer health informatics, mobile menstrual 
applications have highly been incorporated into patient lives and improved patient care. 
With the booming industry of mobile application development, the two operating systems 
(Apple iOS and Google Play) have made available thousands of mobile menstrual apps 
for consumers to download. The challenge for consumers is to not only find a reliable and 
accurate mobile application, but also to find a mobile menstrual application that will cater 
towards their personal needs, such as addressing unique reproductive disorders like 
Polycystic Ovary Syndrome.  
In this thesis, menstrual cycle length data from a literature review and data from 
the Ovulation Menstruation Health Study was compared to show variability in menstrual 
cycle lengths. Menstrual application usage was then examined through data collected 
from the Ovulation and Menstruation Health Study to view the amount of PCOS patients 
who use a tracking method and demographic factors that affected application usage. 
Finally, the top 10 most popular mobile menstrual applications were downloaded and 
evaluated through an adapted version of the APPLICATIONS scoring system. Mobile 
apps were analyzed for comprehensiveness, including aspects of reproductive, digestive, 
and mental health to give a holistic view of one’s bodily changes during the menstrual 
cycle. Additionally, mobile apps were evaluated for the option to track PCOS symptoms. 
With the high variance in menstrual lengths and clear popularity in mobile menstrual 
applications in PCOS groups, it is important to develop an all-encompassing mobile 
menstrual application, where any patient can use consistently and improve understanding 
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of their menstrual cycle.  
 
(Specific Aim #1) DETERMINING THE MOST USED METHOD OF MENSTRUAL 
TRACKING   
 Using the OM study data, relationships between menstrual tracking 
methods and PCOS groups were evaluated. Modules in OM study Pilot successfully 
addressed PCOS symptoms. Questions include assessing whether or not the participant 
has been diagnosed with PCOS or experiences symptoms of PCOS. Further questions on 
vitamins, and dietary supplements, medicines are asked to assess what popular methods 
have been used to reduce symptoms. The OM study pilot questions can be used as a 
model for mobile applications to decide which PCOS-specific features to include when 
designing menstrual tracking applications. 
 
PCOS Status versus Preference of Menstrual Tracking Method 
 Mobile menstrual tracking applications are commonly the most popular form of 
tracking in PCOS patients. In both PCOS groups (physician-diagnosed and self-
diagnosed), there are a significantly lower percentage of people who don’t use any form 
of tracking method at all. In groups with no PCOS, 40.3% of people do not use any 
method as opposed to PCOS groups, where only 27.2% (physician diagnosed) or 25% 
(self-diagnosed) do not use any method of tracking. The prevalence ratio was 1.875 with 
a 95% confidence interval (93% - 38%), which shows a higher probability of PCOS 
patients to use a tracking method. Although sample sizes were small, the trends show that 
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a large number of PCOS patients currently rely on some form of tracking their cycles, 
and further proves the need of a more reliable method.  
 
PCOS Status versus Perception of Health  
 There proves to be a relationship between the PCOS diagnosis and perception of 
health. P values resulted as significant. With the prevalence ratio of 3.35, 95% confidence 
interval (335% - 141%) it is 3.35 more times likely that a patient diagnosed with PCOS 
will view themselves as having fair/poor health as opposed to someone without a PCOS 
diagnosis. This correlates with the high number of PCOS diagnosed patients to use 
menstrual tracking applications to try to improve their overall health. The large amount of 
PCOS patients who believe their health to be fair/poor further highlights the need for 
menstrual tracking applications to include PCOS-specific features. 
  
(Specific Aim #1a) Determining the relationships between demographic factors and 
menstrual tracking methods 
 Aside from PCOS status, various demographic factors were also studied to view 
additional relationships between menstrual tracking methods. 
 
Race/Ethnicity versus Preference of Tracking Method  
 By observation of the bar graphs, preference for tracking methods were similar in 
whites and other races. In “Whites” and “Other” groups, menstrual tracking apps were 
the most popular method, then follows paper calendar, and digital calendar. However, a 
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large majority of participants do not use any method of tracking.  
 
Immigration Status versus Preference of Tracking Method  
 Although there are no observable trends between these two variables, it is obvious 
that people who are born in the U.S. have a higher number of people who track their 
menstrual cycles overall, regardless of tracking method.  
 
Education Level versus Preference of Tracking Method  
 The relationship between the education level and preference for tracking method 
is unclear, but there is a definite trend between education and tracking usage overall. As 
education level increases, there are more people who participate in a tracking method. 
Mobile menstrual tracking applications are still the most popular method in any education 
level group.  
 
Income versus Preference of Menstrual Tracking Method  
 There is a spike in mobile menstrual tracking application usage at the income 
level $25,000-$49,999, where they are the highest preferred method. Overall tracking 
usage decreases significantly after this income range. One explanation for this could be 
that people in higher income brackets are at an older age, and no longer need to track 
menstrual cycles. Another possible explanation could be that people of higher income 
brackets prioritize their careers and do not have the time to track their menstrual cycles.  
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Age versus Preference of Menstrual Tracking Method  
 Menstrual tracking overall, regardless of method, is much more popular among 
younger age groups. There is observable decline in tracking as age increases. Mobile 
menstrual applications still prevail as the most popular method, especially within the age 
bracket 18-29 year olds. This is probably due to the familiarity of this generation to take 
advantage of consumer health informatics, incorporating mobile menstrual applications 
into their personal lives. 
 
Due to the observable trends from the OM Study data, results may prove to be more 
significant if there were a larger and more diverse sample size tested in a future study.  
 
(Specific Aim #1b) Determining variability of menstrual tracking application 
preference by age 
 Menstrual tracking applications clearly predominates as the most popular method 
of tracking menstrual cycles. Among available applications, a relationship is observed 
between age groups and the preferred menstrual application. Because there was a 
significant association between age and preference of menstrual tracking application, a 
moderately strong relationship between the two variables was seen. For groups 18-29, the 
most popular applications were Clue, then PinkPad, and P Tracker coming in third. For 
groups 30-39, there was a significant decrease in users of Clue, but a huge user base for P 
Tracker and Flo. Observing this difference in user base proposes the question of what 
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features specific to each application attracts their respective groups. One possible 
explanation for the difference in user base may have been the time in which the menstrual 
application was launched could correlate with the different age groups. The years that 
each application launched are as follows: Clue (2013), PinkPad (2009), Flo (2016), P 
Tracker (2011), suggesting that there is no apparent correlation between date launched 
and age groups so further analysis on the specifics of each application should be studied. 
A comparison can be done to identify these features, which then could be incorporated 
into one menstrual application that could be customizable and attractive for all age 
groups. 
 
Limitations for this aim was the short time frame for recruiting a diverse cohort in 
the Ovulation and Menstruation Health Study. The cohort was successful in building a 
diverse group of women to extrapolate data from, however, the participants may be 
skewed in terms of being limited in sample size and by the immediate networks of the 
research group. One should be wary in applying observations of this study to the general 
population.  
 
(Specific Aim #2) DETERMINING FUNCTIONALITY OF TOP 10 MENSTRUAL 
TRACKING APPLICATIONS AND INCLUSION OF PCOS-SPECIFIC FEATURES 
  In comparing the functionality of menstrual applications, an adapted 
APPLICATIONS scoring system was used, which includes specific guidelines of what 
constitutes a score of 0 or 1. Categories in the original APPLCATIONS Scoring system 
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include basic components, but assign points in broad categories. The categories from the 
APPLICATION Scoring System, “Contraception”, and “Other – track symptoms”, did 
not specify what contraceptive type or what symptoms are tracked. An application could 
score 1 point in the category of “track symptoms” if the application includes options for 
“breast symptoms”, while another application could include options to track “breast 
symptoms” and “cervical symptoms” and still score 1 point. The APPLICATIONS 
Scoring system does not differentiate on which mobile application tracks appropriate 
symptoms to analyze one’s menstrual cycle. It is not a qualitative assessment, but only 
looks at physical utility values. The adapted APPLICATIONS Scoring system is revised 
to include specific symptoms that would allow a comprehensive view of bodily changes 
that may be related to one’s menstrual cycle, including PCOS related symptoms like 
weight changes, acne, hair growth, and infertility. Clue scored the highest (24 points), 
making it the most comprehensive out of all 10 mobile applications. All applications 
tracked basic features of menstruation, including bleeding, cycle length, abdominal 
cramps, breast symptoms, intercourse and fertility window. However, in order to study 
the complete menstrual cycle, options to track other areas of health including 
mood/stress/social/exercise/ailments should also be monitored. Most applications do not 
include options to track other areas of health, which fails to recognize that menstrual 
health is directly related to digestion, cardiovascular, mental and social health. No 
applications have the option of entering race/ethnicity, which makes it difficult to 
differentiate patterns among different racial/ethnic groups when viewing data collected 
by the mobile application. Most importantly, no applications address all symptoms of 
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PCOS and therefore do not cater towards diverse populations. The adapted 
APPLICATIONS Scoring System created in this study moves toward a system that 
specifies what constitutes a high-quality app that not only supports a certain number of 
features, but reaches a certain standard in each category. Seeing that there are still 
missing features in the current available applications, there is a necessity to develop an 
application which will be inclusive for PCOS users.  
The analysis done for this aim may be limited by the application market used to 
download the most popular applications. The top 10 applications were found through 
Apple iOS and not compared with the top 10 applications found on the Google Play 
Store. Although Clue has taken the forefront in menstrual applications out of the top 10 
from the Apple Application Store, a similar analysis can be done for the most popular 
applications in Google Play to confirm the findings.  
 
Future Directions 
With the future expansion of the OM Pilot cohort to include at least 200 
participants from each race/ethnicity, a re-evaluation of the findings can be done to prove 
significance in a more representative sample size. Additionally, the adapted 
APPLICATIONS system created in this thesis should be a model for future mobile 
application developers to reassess their user population, the gaps in current applications, 
and features to include in future versions of the applications. By including options to 
enter in race/ethnicity among other demographics and menstrual characteristics, data 
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collection through menstrual tracking applications could become an extremely 
advantageous tool in future research.  
 
CONCLUSION 
 
In conclusion, we have confirmed the current popularity of mobile menstrual 
applications for tracking menstrual data, especially in PCOS patients. With the continual 
change and variance in menstrual cycle lengths, there needs to be development of a 
mobile menstrual application that is effective for all populations. Because of the lower 
health perceptions and high menstrual tracking usage seen within PCOS populations, 
mobile applications should move toward addressing these gaps and develop features that 
will enable women to better track their symptoms. Through the adapted APPLICATIONS 
system, major features specific to PCOS patients are still missing in the available 
menstrual applications. The key for menstrual applications is not to replace patient-doctor 
visits, but to increase education, make patients more self-aware, and most importantly act 
as a tool in prevention. 
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